n-methylnicotinamide has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, ME; Jerums, G; Macisaac, R; Panagiotopoulos, S; Thomas, MC; Tsalamandris, C | 1 |
| Arranz, C; Cabrera-Rode, E; Chiong, D; Di Mario, U; Díaz-Díaz, O; Díaz-Horta, O; Domínguez, E; Fernández, T; García, I; González, P; Govea, A; Gutiérrez, A; Hernández, J; León, R; Molina, G; Padrón, S; Prieto, M; Rodríguez, OM; Suárez, R; Tiberti, C; Tillan, J; Vera, M | 1 |
2 trial(s) available for n-methylnicotinamide and Autoimmune Diabetes
| Article | Year |
|---|---|
Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Creatinine; Diabetes Mellitus, Type 1; Glomerular Filtration Rate; Hippurates; Humans; Kidney Tubules; Metabolic Clearance Rate; Niacinamide | 2005 |
Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
Topics: Adolescent; Adult; Autoantibodies; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Genetic Predisposition to Disease; Glucose Tolerance Test; HLA-DR Antigens; Humans; Insulin; Insulin Secretion; Male; Niacinamide; Prediabetic State; Vitamin B Complex | 2006 |